Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-κB activation

Virus Research

Volumn 121, Issue 1, 2006, Pages 51-57

  Mann, Elizabeth A ^a   Stanford, Sandra ^a   Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Hepatitis C virus; NF B regulation; Quasispecies

Indexed keywords

CORE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DATA BASE; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS MUTATION;

AMINO ACID SUBSTITUTION; CELL LINE, TUMOR; HEPACIVIRUS; HEPATITIS C; HUMANS; MUTATION; NF-KAPPA B; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 33745598788     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.04.001     Document Type: Article

References (33)

1. Alam S.S., Nakamura T., Naganuma A., Nozaki A., Nouso K., Shimomura H., and Kato N. Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding region. Acta Med. Okayama 56 3 (2002) 141-147
2. Arenas J.I., Gallegos-Orozco J.F., Laskus T., Wilkinson J., Khatib A., Fasola C., Adair D., Radkowski M., Kibler K.V., Nowicki M., Douglas D., Williams J., Netto G., Mulligan D., Klintmalm G., Rakela J., and Vargas H.E. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J. Infect. Dis. 189 11 (2004) 2037-2046
3. Boya P., Larrea E., Sola I., Majano P.L., Jimenez C., Civeira M.P., and Prieto J. Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression. Hepatology 34 5 (2001) 1041-1048
4. de Lucas S., Bartolome J., Amaro M.J., and Carreno V. Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation. Antiviral Res. 60 2 (2003) 117-124
5. Di Bisceglie A.M. Natural history of hepatitis C: its impact on clinical management. Hepatology 31 4 (2000) 1014-1018
6. Ding W.X., and Yin X.M. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J. Cell. Mol. Med. 8 4 (2004) 445-454
7. Gaweco A.S., Wiesner R.H., Porayko M., Rustgi V.K., Yong S., Hamdani R., Harig J., Chejfec G., McClatchey K.D., and Van Thiel D.H. Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation. Hepatology 31 5 (2000) 1183-1191
8. Gong G., Waris G., Tanveer R., and Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. U.S.A. 98 17 (2001) 9599-9604
9. Heyninck K., Wullaert A., and Beyaert R. Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. Biochem. Pharmacol. 66 8 (2003) 1409-1415
10. Hino K., Yamaguchi Y., Fujiwara D., Katoh Y., Korenaga M., Okazaki M., Okuda M., and Okita K. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study. J. Viral. Hepat. 7 1 (2000) 36-42
11. Hoshida Y., Kato N., Yoshida H., Wang Y., Tanaka M., Goto T., Otsuka M., Taniguchi H., Moriyama M., Imazeki F., Yokosuka O., Kawabe T., Shiratori Y., and Omata M. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8. J. Infect. Dis. 192 2 (2005) 266-275
12. Joo M., Hahn Y.S., Kwon M., Sadikot R.T., Blackwell T.S., and Christman J.W. Hepatitis C virus core protein suppresses NF-{kappa}B activation and cyclooxygenase-2 expression by direct interaction with I{kappa}B kinase {beta}. J. Virol. 79 12 (2005) 7648-7657
13. Kim W.H., Hong F., Jaruga B., Hu Z., Fan S., Liang T.J., and Gao B. Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms. FASEB J. 15 13 (2001) 2551-2553
14. Kountouras J., Zavos C., and Chatzopoulos D. Apoptosis in hepatitis C. J. Viral. Hepat. 10 5 (2003) 335-342
15. Kuiken C., Yusim K., Boykin L., and Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 21 3 (2005) 379-384
16. Macdonald A., Crowder K., Street A., McCormick C., Saksela K., and Harris M. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J. Biol. Chem. 278 20 (2003) 17775-17784
17. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., and Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 9286 (2001) 958-965
18. Marusawa H., Hijikata M., Chiba T., and Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J. Virol. 73 6 (1999) 4713-4720
19. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Viral. Hepat. 7 1 (2000) 2-14
20. Pawlotsky J.M., Pellerin M., Bouvier M., Roudot-Thoraval F., Germanidis G., Bastie A., Darthuy F., Remire J., Soussy C.J., and Dhumeaux D. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J. Med. Virol. 54 4 (1998) 256-264
21. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 9055 (1997) 825-832
22. Qin H., Shire N.J., Keenan E.D., Rouster S.D., Eyster M.E., Goedert J.J., Koziel M.J., and Sherman K.E. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 105 2 (2005) 533-541
23. Ray R.B., and Ray R. Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol. Lett. 202 2 (2001) 149-156
24. Ray R.B., Steele R., Basu A., Meyer K., Majumder M., Ghosh A.K., and Ray R. Distinct functional role of hepatitis C virus core protein on NF-kappaB regulation is linked to genomic variation. Virus Res. 7 1 (2002) 21-29
25. Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. J. Mol. Biol. 313 3 (2001) 451-464
26. Schulze zur Wiesch J., Schmitz H., Borowski E., and Borowski P. The proteins of the hepatitis C virus: their features and interactions with intracellular protein phosphorylation. Arch. Virol. 148 7 (2003) 1247-1267
27. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 19 (2001) 2390-2400
28. Shrivastava A., Manna S.K., Ray R., and Aggarwal B.B. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J. Virol. 72 12 (1998) 9722-9728
29. Tai D.I., Tsai S.L., Chang Y.H., Huang S.N., Chen T.C., Chang K.S., and Liaw Y.F. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89 11 (2000) 2274-2281
30. Watashi K., Hijikata M., Marusawa H., Doi T., and Shimotohno K. Cytoplasmic localization is important for transcription factor nuclear factor-kappa B activation by hepatitis C virus core protein through its amino terminal region. Virology 286 2 (2001) 391-402
31. Yoshida H., Kato N., Shiratori Y., Otsuka M., Maeda S., Kato J., and Omata M. Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J. Biol. Chem. 276 19 (2001) 16399-16405
32. You L.R., Chen C.M., and Lee Y.H. Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J. Virol. 73 2 (1999) 1672-1681
33. Zhu N., Khoshnan A., Schneider R., Matsumoto M., Dennert G., Ware C., and Lai M.M. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72 5 (1998) 3691-3697